This contrasts with the MMTV-neu primary tumors reported here, in which TAMs are present in the primary tumor, and this discrepancy is likely due to differences between the transgenes used in the models; tumor-associated inflammation is more pronounced in polyoma middle T-driven tumors than in those driven by HER2/neu [40]. The gene discussed is ERBB2; the disease is neoplasm.